Jonathon B Cohen

Jonathon B Cohen

UNVERIFIED PROFILE

Are you Jonathon B Cohen?   Register this Author

Register author
Jonathon B Cohen

Jonathon B Cohen

Publications by authors named "Jonathon B Cohen"

Are you Jonathon B Cohen?   Register this Author

57Publications

1732Reads

8Profile Views

Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.

Clin Lymphoma Myeloma Leuk 2019 Jun 12;19(6):e312-e320. Epub 2019 Mar 12.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.03.006DOI Listing
June 2019

When to use stem cell transplant in mantle cell lymphoma.

Expert Rev Hematol 2019 Apr 7;12(4):207-210. Epub 2019 Mar 7.

b Department of Hematology and Medical Oncology , Emory University Winship Cancer Institute , Atlanta , GA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1588106DOI Listing
April 2019

Intrathecal Central Nervous System Prophylaxis in Patients With Diffuse Large B-cell Lymphoma at an Academic Healthcare System.

Clin Lymphoma Myeloma Leuk 2019 Feb 17;19(2):89-94. Epub 2018 Nov 17.

Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.11.014DOI Listing
February 2019

Novel therapies for relapsed/refractory aggressive lymphomas.

Authors:
Jonathon B Cohen

Hematology Am Soc Hematol Educ Program 2018 11;2018(1):75-82

Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2018.1.75DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245978PMC
November 2018

Revised Dose Ramp-Up to Mitigate the Risk of Tumor Lysis Syndrome When Initiating Venetoclax in Patients With Mantle Cell Lymphoma.

J Clin Oncol 2018 Oct 25:JCO1800359. Epub 2018 Oct 25.

Matthew S. Davids, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Gottfried von Keudell, Yale School of Medicine, New Haven, CT; Craig A. Portell, University of Virginia Health System, Charlottesville, VA; Jonathon B. Cohen, Winship Cancer Institute of Emory University, Atlanta, GA; David C. Fisher, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Francine Foss, Yale School of Medicine, New Haven, CT; Andrew W. Roberts, Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia; John F. Seymour, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia; Rod A. Humerickhouse, AbbVie, Chicago, IL; and Constantine S. Tam, Royal Melbourne Hospital, Peter MacCallum Cancer Centre, St Vincent's Hospital, and University of Melbourne, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.00359
Publisher Site
http://dx.doi.org/10.1200/JCO.18.00359DOI Listing
October 2018

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 05 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075855PMC
May 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.

Am Soc Clin Oncol Educ Book 2017 ;37:512-525

From Emory University, Atlanta, GA; City of Hope, Duarte, CA; Washington University School of Medicine, St. Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_175448DOI Listing
December 2017

PI3K Inhibitors: Understanding Toxicity Mechanisms and Management.

Oncology (Williston Park) 2017 11;31(11):821-8

View Article

Download full-text PDF

Source
November 2017

mutations in MCL: more therapy is not better.

Authors:
Jonathon B Cohen

Blood 2017 10;130(17):1876-1877

EMORY UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-803551DOI Listing
October 2017

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma.

Leuk Lymphoma 2017 09 20;58(9):1-2. Epub 2017 Feb 20.

b Division of Hematology , The Ohio State University James Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1289527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497734PMC
September 2017

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.

Blood 2017 02 12;129(5):561-564. Epub 2016 Dec 12.

Winship Cancer Institute, Emory University, Atlanta, GA; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-08-685073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290981PMC
February 2017

Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.

Cancer 2016 08 6;122(15):2356-63. Epub 2016 May 6.

Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30068DOI Listing
August 2016

Next-generation surveillance strategies for patients with lymphoma.

Future Oncol 2015 ;11(13):1977-91

Department of Hematology & Medical Oncology, Emory University, 1365 Clifton Road NE, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519355PMC
April 2016

GIFT4 fusokine converts leukemic B cells into immune helper cells.

J Transl Med 2016 04 27;14(1):106. Epub 2016 Apr 27.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, 1365B Clifton Road, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-0865-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847253PMC
April 2016

A Clinician's Approach to Double-Hit Lymphoma: Identification, Evaluation, and Management.

J Oncol Pract 2016 Mar;12(3):232-8

Emory University, Atlanta, GA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.009647DOI Listing
March 2016

Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.

Clin Lymphoma Myeloma Leuk 2015 Sep 3;15(9):514-8. Epub 2015 Jul 3.

Department of Hematology and Medical Oncology, Emory University, Winship Cancer Institute, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.06.009DOI Listing
September 2015

A Plethora of Novel Therapies--Which One to Choose?

Oncology (Williston Park) 2015 Jul;29(7):499-500

View Article

Download full-text PDF

Source
July 2015

Role of allogeneic stem cell transplantation in mantle cell lymphoma.

Eur J Haematol 2015 Apr 18;94(4):290-7. Epub 2014 Oct 18.

Division of Stem Cell and Immune Therapy, Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575931PMC
April 2015

Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era.

Leuk Lymphoma 2015 Mar 19;56(3):557-8. Epub 2014 Nov 19.

Division of Bone Marrow and Stem Cell Transplantation/Department of Hematology/Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.970547DOI Listing
March 2015

Optimal disease surveillance strategies in non-Hodgkin lymphoma.

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):481-7. Epub 2014 Nov 18.

Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.481DOI Listing
December 2014

Peripheral T-cell lymphoma: what's the role for transplant?

Oncology (Williston Park) 2013 Sep;27(9):891-2

Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
September 2013

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.

Case Rep Hematol 2012 7;2012:589718. Epub 2012 Nov 7.

Division of Hematology, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, 320 W 10th Avenue, B354 Starling Loving Hall, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/589718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502771PMC
December 2012

Evaluation and management of lymphoma and leukemia in pregnancy.

Clin Obstet Gynecol 2011 Dec;54(4):556-66

Department of Internal Medicine, Division of Hematology, The Arthur G. James Comprehensive Cancer Center and The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/GRF.0b013e318236e68aDOI Listing
December 2011